Termination TerugBetaalRegeling Forxiga® - Hartfalen
From July 1st 2021 onwards, Forxiga® (dapagliflozine) 10 mg for the treatment of heart failure with reduced ejection fraction...
Amendment to TerugBetaalRegeling Lokelma®
TBR Nederland hereby informs you that it will make a change to a repayment scheme starting from now. This concerns the medicine...
Reimbursement Scheme FRAGMIN® 2500
The health insurer does not fully reimburse FRAGMIN® 2500. The producer of this medicine has therefore asked TBR Nederland to...
Simplified TerugBetaalRegeling Broxil®
The health insurer will not reimburse the cost of Broxil® 125 mg / 5 mL, powder for oral suspension in full. The producer of this...
Reimbursement Scheme Forxiga® - Hartfalen
The health insurer does not yet fully reimburse Forxiga® (dapagliflozine) 10 mg for the treatment of symptomatic chronic heart...
Select your medicine
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine